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COMMENTARY
Not All Mice Are the Same:
Standardization of Animal
Research Data Presentations the editors of several journals, we have joinedAforces to highlight the importance of providing
essential details related to animal experiments, particularly
for studies that include mouse work. This is a critical issue
that partially underlies the problem of irreproducible re-
sults that is attracting international attention1 as well as the
attention of funding agencies such as the National Institutes
of Health.2 For mouse studies, this can be a daunting
problem given that many manuscripts do not provide suf-
ﬁcient details regarding the number of animals used for a
given experiment, the sex of the animals, their age, and in
some cases identiﬁcation of the background genetic strains.
Other variables that can also play an important role in
shaping experimental ﬁndings and conclusions are the
microbiome,3 making co-housing of control and genetically
altered animals essential, diet, and even the composition of
animal bedding.4
Several journals have supported the ARRIVE (Animal
Research: Reporting of In Vivo Experiments) Guidelines that
were originally proposed in 2010,5 which include an
extensive checklist of information related to animal exper-
iments that is considered essential to provide. However, itFigure 1. Key elements to consider and highlight for mouse rela
that need to be considered when planning mouse (and other
cation. FVB and C57BL/6 represent, as examples, commonly
important (eg, FVB/NJ from The Jackson Laboratory vs FVB/N
schematic, such as environment conditions, are highlighted
littermate mice.
Celluseems that the reporting standards may not have improved
very much since initial presentation and acceptance of the
guidelines by multiple journals.6 Several reasons may ac-
count for the observed ‘noncompliance’ with the ARRIVE
guidelines,6 including difﬁculty ensuring that reviewers and
editors carefully assess whether the guidelines have been
followed, and the possibility that some authors may indicate
that the guidelines have been followed (based on author
interpretation and not because of any malintent) when in
reality not all components have been pursued. Reviewers
and editors frequently ask authors to expand on some of
these necessary details, but the reviewers often focus on
separate important issues while the speciﬁcs that are
related to the mouse work may be overlooked. Another
barrier might be the extensive nature of the ARRIVE
checklist, which may not apply fully to many submitted
manuscripts. This is relevant, because scientists (and phy-
sicians) are now facing an increasing barrage of regulatory
documentation paperwork that is limiting their time for
scientiﬁc investigation (or for their patients). Notwith-
standing this limitation, we are uniting from different
journals to highlight the importance of documenting what
we consider to be the minimum list of information to
improve transparency and the quality of data reporting. Our
purpose is not to legislate a “one size ﬁts all” philosophy, but
rather to maximize the possibility of other researchers
reproducing study ﬁndings from the same wild-type orted studies. The schematic shows several important criteria
animal) experiments, and when submitting work for publi-
used mouse strains. Of note, vendor sources can also be
Tac from Taconic). Other considerations not displayed in the
in the text. þ/þ, wild-type littermate mice; -/-, knockout
lar and Molecular Gastroenterology and Hepatology 2016;2:391–393
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highlighting the criteria listed below in our Instructions to
Authors, and some of our journals will also introduce an
author-friendly checklist that will need to accompany
manuscripts that use mice and other in vivo experimental
models.
The criteria that will be expected of authors include the
following information (Figure 1):
 Sex and age of mice (or other in vivo experimental
models) for all the experiments;
 The genetic background(s) of the mice or other
experimental in vivo models;
 For transgenic or genetic mouse models, whether the
controls were sibling littermates or were purchased
separately (if purchased separately, were the animals
cohoused to minimize potential microbiome effects);
 Speciﬁcs of the animal diet composition;
 Whether mice were fasted (and for how long) or not
before a challenge or assessment is carried out;
 Type of bedding, caging system, and enrichment used
for housing the mice; and
 If interventions were done, were they done during the
light or dark cycle.
Power analyses can be useful to estimate appropriate
sample sizes; however, the standard deviations for relevant
dependent variables are often not known a priori. There-
fore, it is critical that the number of animals for each
experimental arm or condition is reported together with
biological replication of statistically signiﬁcant results
derived from independent groups of animals.
There are also other variables that may need to be
considered that we have not included as primary expec-
tations, particularly those related to behavior, stress, and
growth conditions. These variables include acclimation to
a new environment (eg, when animals are shipped by the
vendor or moved from the animal facility to a procedure
room), other environment effects (eg, temperature, hu-
midity, noise), littermate size, and pheromone effects.
These additional variables can be very important
depending on the biologic readout. Moreover, environ-
ment effects, such as avoidance of large temperature
changes unless approved as part of an animal protocol, are
expected to be part of the normal procedures of humane
treatment of animals.
What can journals and research institutions do moving
forward toward a path to implementation?7 Certainly all
stakeholders need to be engaged and many funding agencies
now expect that applicants pay closer attention to this
important issue, as exempliﬁed by the recent requirement
from the National Institutes of Health to include a section
titled Authentication of Key Biological and/or Chemical Re-
sources in grant applications.8 For journals, setting and
enforcing clear expectations to authors, reviewers, and ed-
itors will be essential, because a checklist alone will not besufﬁcient, while making the process as user-friendly as
possible. For institutions, several approaches can be
considered and implemented, that are aimed at in-
vestigators and trainees. For example, the curricula for
students who are enrolled in bioscience-related under-
graduate and graduate programs should include training not
only in the ethics in conducting research, but also in the
basic tenets of conducting and designing animal experi-
ments. It is important for this to start early and to be
reinforced as training advances. Similarly, postdoctoral fel-
lows in biomedical disciplines should be expected to enroll
in similar workshops that would be offered by their home
institutions. For such workshops, centralized (rather than
department- or unit-speciﬁc) oversight and administration
will more likely ensure uniformity and implementation. We
look forward to working together on this important effort
and to receiving feedback from our authors, reviewers and
readers.
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